Results 71 to 80 of about 4,771 (191)

Dual Role of LBH589 in Triple‐Negative Breast Cancer: Inhibition of Tumor Growth and Enhancement of Antitumor Immunity

open access: yesCancer Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background Epigenetic dysregulation, particularly aberrant histone deacetylase (HDAC) activity, plays a critical role in the progression of breast cancer. Although HDAC inhibitors (HDACi) have demonstrated antitumor potential in preclinical studies, none have been approved for breast cancer due to inconsistent efficacy across different ...
Liang Anjing   +5 more
wiley   +1 more source

RETRACTED ARTICLE: Belinostat suppresses cell proliferation by inactivating Wnt/β-catenin pathway and promotes apoptosis through regulating PKC pathway in breast cancer

open access: yesArtificial Cells, Nanomedicine, and Biotechnology, 2019
We, the Editors and Publisher of the journal  Artificial Cells, Nanomedicine, and Biotechnology, have retracted the following article:Pengwei Lu, Yuanting Gu, Lin Li, Fang Wang, Xue Yang & Yunqing Yang (2019) Belinostat suppresses cell proliferation by ...
Pengwei Lu   +5 more
doaj   +1 more source

ATF4‐mediated stress response as a therapeutic vulnerability in chordoma

open access: yesMolecular Oncology, Volume 20, Issue 4, Page 1008-1021, April 2026.
We screened 5 chordoma cell lines against 100+ inhibitors of epigenetic and metabolic pathways and kinases and identified halofuginone, a tRNA synthetase inhibitor. Mechanistically halofuginone induces an integrated stress response, with eIF2alpha phosphorylation, activation of ATF4 and its target genes CHOP, ASNS, INHBE leading to cell death ...
Lucia Cottone   +11 more
wiley   +1 more source

New developments in the treatment of peripheral T-cell lymphoma – role of Belinostat

open access: yesCancer Management and Research, 2015
Peter Reimer Clinic for Hematology, Medical Oncology and Stem Cell Transplantation, Evangelisches Krankenhaus Essen-Werden gGmbH, Essen, Germany Abstract: Peripheral T-cell lymphomas (PTCL) represent a heterogeneous group of rare malignancies that with ...
Reimer P
doaj  

Identification of Histone Deacetylase Inhibitor Targeting Type I Interferon and B Cell Abnormalities in Systemic Lupus Erythematosus

open access: yesArthritis &Rheumatology, Volume 78, Issue 4, Page 880-895, April 2026.
Objective Systemic lupus erythematosus (SLE) is characterized by increased Type I interferon (IFN‐I) and autoantibody production. This study aimed to identify drugs that can inhibit both IFN‐I and autoantibody production. Methods We identified an inhibitor of IFN‐I production from a chemical library.
Takehiro Hirayama   +16 more
wiley   +1 more source

Combining Small‐Molecular Compounds With CAR T‐Cell Therapy: Novel Strategies for Enhanced Cancer Immunotherapy

open access: yesCancer Innovation, Volume 5, Issue 2, April 2026.
Chimeric antigen receptor (CAR) T‐cell therapy, although revolutionary for haematological malignancies, faces significant challenges, including T‐cell exhaustion, limited persistence, and treatment‐related toxicity. The integration of small‐molecule compounds offers a promising strategy to overcome these limitations.
Rangzi Yi   +3 more
wiley   +1 more source

Polymorphic Forms Of Belinostat and Processes For Preparation Thereof

open access: yes, 2016
The present invention relates to the polymorphic forms of Belinostat. The invention also relates to the process for the preparation of the polymorphic forms of Belinostat.
Cabri W, Lahiri, G., Singh, S.
core  

Prolonging the Half-Life of Histone Deacetylase Inhibitor Belinostat via 50 nm Scale Liposomal Subcutaneous Delivery System for Peripheral T-Cell Lymphoma

open access: yes, 2020
Lymph node metastasis is an aggressive condition characterized by poor treatment outcomes and low overall survival. Belinostat is a novel histone deacetylase (HDAC) inhibitor approved by the Food and Drug Administration (FDA) for the treatment of ...
Wei-Ting Liao   +6 more
core   +1 more source

Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth

open access: yesInternational Journal for Parasitology: Drugs and Drug Resistance, 2017
Malaria, schistosomiasis and leishmaniases are among the most prevalent tropical parasitic diseases and each requires new innovative treatments. Targeting essential parasite pathways, such as those that regulate gene expression and cell cycle progression,
Ming Jang Chua   +10 more
doaj   +1 more source

Einfluss des Histondeacetylase-Inhibitors Belinostat auf das Wachstum von Pankreastumorzellen in vivo und in vitro [PDF]

open access: yes, 2011
Das Pankreaskarzinom hat auf Grund seiner hohen Mortalitätsrate und trotz verbesserter Diagnose- und Therapiemöglichkeiten nach wie vor eine schlechte Prognose.
Arnold, Stefanie
core   +1 more source

Home - About - Disclaimer - Privacy